Search / Trial NCT00001506

Evaluation and Treatment of Patients With Dermatologic Diseases

Launched by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) · Nov 3, 1999

Trial Information

Current as of December 26, 2024

Recruiting

Keywords

Natural History Consultation Standard Therapy Standard Tests Training

ClinConnect Summary

This clinical trial is focused on understanding and treating skin diseases, including those related to other health conditions that show symptoms on the skin. It aims to gather information about how these diseases progress and how well different treatments work. Patients of all ages, genders, and backgrounds who have skin conditions or related systemic diseases may be eligible to participate. However, pregnant or breastfeeding women will only take part if the tests and medications are proven to be safe for their babies. Each participant will need a doctor who will manage their overall care during and after the trial.

Participants can expect a thorough evaluation and treatment using standard medical practices. They will undergo tests and procedures that involve collecting samples of blood and skin, which will be analyzed to help establish their diagnosis and track their response to treatment. This study is currently looking for volunteers, and it’s important to note that anyone who might struggle to follow the study requirements or could face higher medical risks will not be included.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Patients of any age (only viable neonates will enroll in the study), of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations that will help the Branch fulfill the objectives.
  • Women who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child.
  • Patients must have a referring physician who will continue to assume primary medical responsibility of care for the patient during and after enrollment in this protocol.
  • EXCLUSION CRITERIA:
  • Any participant who, in the investigator s opinion, would be unable to comply with study requirements or for whom participation may pose a greater medical risk.

Trial Officials

Edward W Cowen, M.D.

Principal Investigator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

About National Institute Of Arthritis And Musculoskeletal And Skin Diseases (Niams)

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a pivotal component of the National Institutes of Health (NIH) dedicated to advancing research and knowledge in the fields of arthritis, musculoskeletal disorders, and skin diseases. NIAMS sponsors a wide range of clinical trials aimed at improving the diagnosis, treatment, and prevention of these conditions. By fostering innovative research, collaborating with healthcare professionals, and engaging with patient communities, NIAMS strives to enhance the quality of life for individuals affected by these diseases, while promoting scientific discovery and public health initiatives.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials